Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 0 | 0 | 0 | 0 |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | 24.2M | 23.1M | 25.3M | 23.1M |
| Selling general and admin | 12.4M | 7.8M | 8.5M | 7.6M |
| Other operating expenses | — | — | — | — |
| Operating income | -36.6M | -30.9M | -33.8M | -30.7M |
| Non operating interest income | ||||
| Income | 4.4M | 4.9M | 5.5M | 5.7M |
| Expense | — | — | — | — |
| Other income expense | 205K | 94K | -3K | -2K |
| Pretax income | -32.0M | -25.9M | -28.3M | -25.0M |
| Tax provision | — | — | — | — |
| Net income | -32.0M | -25.9M | -28.3M | -25.0M |
| Basic EPS | -0.4 | -0.4 | -0.4 | -0.3 |
| Diluted EPS | -0.4 | -0.4 | -0.4 | -0.3 |
| Basic average shares | 73.9M | 73.6M | 73.6M | 73.5M |
| Diluted average shares | 73.9M | 73.6M | 73.6M | 73.5M |
| EBITDA | -34.3M | -28.6M | -31.4M | -28.5M |
| Net income from continuing op. | -32.0M | -25.9M | -28.3M | -25.0M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |